Clinical Impact of Red Cell Storage Age

Sponsor
University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT05482737
Collaborator
(none)
33,000
1
61
540.6

Study Details

Study Description

Brief Summary

The recent four RCTs evaluating effects of RBC storage age on morbidity and mortality found no statistically significant adverse effects of longer stored RBC compared to shorter storage ages. Unfortunately, none of these RCTs had sufficient numbers of subjects receiving RBC at either storage age extreme to identify consequences of RBC transfusion at these limits. To better investigate effects of RBC storage age on clinical outcomes, this study will perform secondary meta-analyses of merged common patient data elements -individual patient data (IPD) meta-analysis (IPDMA) - from the nearly 33,000 subjects enrolled in the four RCTs.

Condition or Disease Intervention/Treatment Phase
  • Other: no intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
33000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical Impact of Red Cell Storage Age: Individual Patient Data Meta-Analysis of Four Recent Large Randomized Trials
Actual Study Start Date :
Jul 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Reference group

Transfused RBC stored 8-35 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

less than or equal 7 days

Transfused RBC stored =<7 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

more than 7 days

Transfused RBC stored <7 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

less that or equal 10 days

Transfused RBC stored =<10 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

more that 10 days

Transfused RBC stored >10 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

more than 35 days

Transfused RBC stored >35 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

less than or equal 35 days

Transfused RBC stored =<35 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

less than 18 days

Transfused RBC stored <18 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

more than or equal 18 days

Transfused RBC stored =>18 days

Other: no intervention
This is an observational retrospective study (meta-analysis)

Outcome Measures

Primary Outcome Measures

  1. All-cause mortality [28 days after transfusion]

    Estimate the effect of transfused RBC storage-age on time to all-cause mortality

  2. Hospital length of stay [after transfusion through 28 days]

    Estimate the effect of transfused RBC storage-age on hospital stay

Secondary Outcome Measures

  1. All-cause mortality at 28 days for long-storage [28 days after transfusion]

    all-cause mortality at 28 days comparing subjects who received (one or more) RBC unit ≥ 35 days vs. no unit > 35 days

  2. 28 day mortality for short-storage [28 days after transfusion]

    28 day mortality for subjects who received (one or more) RBC unit ≤ 7 days vs. no unit ≤ 7 days

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Received at least one RBC transfusion

  • =18 years of age

Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Marie Steiner, MD, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT05482737
Other Study ID Numbers:
  • Pending 4
First Posted:
Aug 1, 2022
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Minnesota

Study Results

No Results Posted as of Aug 11, 2022